RSS Amplifier

Africa Health Ventures · Feb 4, 2026

Africa Health Ventures #23: Big Tech is in the Room

0
Sign in to vote or save

Rowena Luk · Africa Health Ventures

If you are one of the hundreds of startups in Kenya and Nigeria building AI chatbots, your world was also rocked when OpenAI announced ChatGPT Health on Jan 7. This was followed by OpenAI for Healthcare on Jan 8; Claude for Healthcare on Jan 11; and, intriguingly, OpenAI’s “$100 million” acqui-hire of 4-person Torch on Jan 12. Big Tech is in the room and it knows the value of healthcare.

The question many founders are asking: does it even make sense to step up when there are already so many giants in the room? Let’s face it: hundreds of startups and would-be startups will be wiped out by these new offerings. Pure-play AI chatbots, personalized care portals, and intranet search will be commodities.

And yet, there is more work to do. Ironically, the things that make it difficult to build in healthcare are the same things that make it so compelling. These struggles are what create necessary and defensible value. Regulatory approval. Government partnerships. Economies of scale on physical assets. Enterprise engagement and workflow optimization. The infinite mysteries and the messy biology of our own bodies. Relationships. Trust.

So yes, Big Tech is here and some innovations are dead already. The opportunity that remains is not in chat interfaces or content aggregation. It’s in doing the hard, unsexy work that turns technology into real outcomes. Founders who can navigate regulation, embed into workflows, earn institutional trust, and build with governments and enterprises won’t be displaced—They’ll be indispensable. The room is crowded, but there’s still plenty of space for the hands-on work that actually moves health systems forward.

Read on for 18 new deals, 24 opportunities, and 14 upcoming events relevant for healthcare innovators and investors in Africa.

  • Nawah Scientific raised $23 million in a Series A to expand its cloud-lab footprint across MENA and Africa. The Egyptian life-sciences startup enables remote access to advanced laboratory testing for researchers and enterprises.

  • GOAL 3 has been awarded a €1 million Eurostars grant alongside partner Picterus to develop JaundiceCARE, a new neonatal jaundice screening and management solution.

  • Rology has closed a growth funding round with participation from the Philips Foundation, Johnson & Johnson Impact Ventures, Sanofi Global Health Unit’s Impact Fund, and MIT Solve Innovation Future. The Egyptian AI‑assisted teleradiology platform connects hospitals with remote radiologists.

  • Sora raised an additional $2.5 million in seed funding. The Japan-headquartered startup uses drones and AI to map disease environments and support targeted malaria control and other public health interventions across Africa.

  • FitXpert secured a seven-figure strategic investment from Foras Investment. The Egyptian SaaS startup provides a unified fitness and nutrition management system for trainers, clinics and wellness centres.

  • Immobazyme raised $1.5 million from the University Technology Fund (UTF II), alongside Fireball Capital and Stellenbosch University Enterprises. The South African biotech uses precision fermentation to develop and scale biologics for therapeutic, research, and industrial use.

  • Mamy Eyewear received an investment from Ikemori Venture Support to grow its footprint across East Africa. The Kenyan optical retailer offers affordable, tech-driven eyecare solutions including AI-powered eye exams.

  • mPharma secured a strategic investment from Growth Investment Partners (GIP) backed by British International Investment to accelerate its healthcare expansion in West Africa. The Ghana-based healthtech optimises pharmaceutical supply chains and operates a franchise pharmacy model.

  • Namola was acquired by Community Wolf to consolidate South Africa’s safety-tech ecosystem. Namola is a South African emergency-response app that lets users quickly request medical, security, or roadside assistance.

  • CarePoint secured financing from JICA to support regional expansion, including entry into Egypt. The company operates tech-enabled clinics that blend physical care delivery with digital health tools.

  • Africa’s Business Heroes 2025 awarded NuvoteQ $150,000 for its clinical research tools to support the design, execution, and management of clinical trials.

  • Enza Capital exited its stake in Quro Medical to Netcare Group, South Africa’s largest private hospital group. Quro Medical extends healthcare services from facilities to the home, combining in-home clinical care with telemedicine and digital monitoring.

  • Alta Semper Fund II secured $38 million from EIB Global to scale pharmaceutical manufacturing, healthcare services, and life sciences companies to strengthen local drug production and healthcare access across Africa.

  • Adenia Partners has acquired a majority stake in Egypt’s Parkville Pharmaceuticals, which manufactures therapeutic, cosmeceutical, and nutraceutical products.

  • Salt Capital & South Suez Capital have completed the acquisition of Welwitschia Hospital, ERAD Radiology, and Spescare Namibia in a strategic healthcare deal strengthening Namibia’s hospital and diagnostic network.

  • Carrefour Medical has secured €18 million from the International Finance Corporation (IFC) to boost local manufacturing and distribution of medical equipment and consumables in Senegal.

  • AdiWale Growth Fund made an undisclosed investment into a Guinea-based healthcare provider to boost clinical capacity and expand services.

  • The Patrick J. McGovern Foundation disclosed $76 million allocated across 2025 towards ethical AI in low-resource countries. This included grants to Jacaranda Health, Audere, Maisha Meds, Nexleaf Analytics, and Open Function.

  • The Gates Foundation and OpenAI committed $50 million to the Horizon1000 initiative, aiming to deploy AI‑powered tools to 1,000 primary healthcare clinics across Africa—starting with Rwanda—to assist health workers, improve clinical decision‑making, and strengthen care delivery by 2028.

  • The African Development Bank Group (AfDB) approved $30 million in financing to expand Rwanda’s Centre of Excellence for Biomedical Engineering and e‑Health.

  • GAVI the Vaccine Alliance announced a new collaboration with partners including 500 Global, The Coca-Cola Foundation, Tony’s Chocolonely, UBS Optimus Foundation, Bayer Foundation, Zipline and the Elton John AIDS Foundation to accelerate vaccine innovation and expand access to immunisation and primary healthcare. This effort builds on an early pledge of CAD 40 million from Grand Challenges Canada through GAVI’s Innovation Scale-Up Facility.

  • Biomine won the healthtech category of the 2025 South African Startup Awards for its work in gut microbiome health diagnostics.

  • Tech in Africa published an overview of regulatory frameworks relevant for healthtech founders in Africa navigating regulatory approval and compliance.

  • Case Study: Salient Advisory recently published two side-by-side case studies on digitizing the last mile of healthcare delivery. They evaluate the pros and cons of an open-source, donor-funded healthtech platform (RHOS) alongside a proprietary, market-driven healthtech offering (ElephantOS).

Up to $25 million to improve access to maternal and newborn health products. Private companies and consortia are eligible to apply.

In case you missed it, last week we released our annual review of healthcare startups, funding, and investors in Africa in 2025. Despite a tumultuous year, healthcare sector funding surged by over 200% in 2025, the largest growth seen in any sector on the continent. Read the full report here.

What were your milestones in 2025 and hopes for 2026? Let us know on LinkedIn. You can also:

👍Follow us on LinkedIn

🪙Nominate a startup for seed funding

🎙️Subscribe to our podcast on Spotify, Apple or wherever you get your podcasts

This newsletter is public. Please share it with others who might find it useful.

Share

No posts

Read the original on rowenaluk.substack.com

Comments

Nothing yet. Say the first thing.

    Sign in to join the conversation.